VMP 42214411000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Moxonidine 300microgram tablets
BNF code 0205020M0AAACAC
Virtual Therapeutic Moiety Moxonidine
Date identifier became valid 1 Sep 2023
Previous product identifier 408604009
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Moxonidine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 300.000
Strength value numerator unit microgram
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Moxonidine 300microgram tablets (A A H Pharmaceuticals Ltd)
Moxonidine 300microgram tablets (Alliance Healthcare (Distribution) Ltd)
Moxonidine 300microgram tablets (Medihealth (Northern) Ltd)
Moxonidine 300microgram tablets (Necessity Supplies Ltd)
Moxonidine 300microgram tablets (Phoenix Healthcare Distribution Ltd)
Moxonidine 300microgram tablets (Sandoz Ltd)
Moxonidine 300microgram tablets (Sigma Pharmaceuticals Plc)
Moxonidine 300microgram tablets (Teva UK Ltd)
Physiotens 300microgram tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Moxonidine 300microgram tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback